Skip to content


Vectibix (panitumumab) is an antibody pharmaceutical. Panitumumab was first approved as Vectibix on 2006-09-27. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. The pharmaceutical is active against epidermal growth factor receptor.
Trade Name Vectibix
Common Name Panitumumab
Indication colorectal neoplasms
Drug Class Monoclonal antibodies
Get full access now